Daniel González de Requena

Liver toxicity caused by nevirapine

Daniel González de Requena, Marina Núñez, Inmaculada Jiménez‐Nácher et al. · AIDS · 2002 · 177 citations

Pharmacy, Pharmacology, Pharmacotherapy +15

Analyzing Sleep Abnormalities in HIV‐Infected Patients Treated with Efavirenz

Lucía Gallego, Pablo Barreiro, Rafael del Río Villegas et al. · Clinical Infectious Diseases · 2004 · 143 citations · Full text

Nursing, Infectious Diseases, Pharmacotherapy +16

Prevention of nevirapine-associated exanthema using slow dose escalation and/or corticosteroids

Pablo Barreiro, Vincent Soriano, Vicente Estrada et al. · AIDS · 2000 · 81 citations

Medicine, Pharmacology, Pharmacotherapy +9

Correlation Between Lopinavir Plasma Levels and Lipid Abnormalities in Patients Taking Lopinavir/Ritonavir

Daniel González de Requena, Francisco J. Blanco, Teresa García-Benayas et al. · AIDS Patient Care and STDs · 2003 · 70 citations

Medicine, Pharmacology, Pharmacotherapy +17

Nevirapine Plasma Exposure Affects both Durability of Viral Suppression and Selection of Nevirapine Primary Resistance Mutations in a Clinical Setting

Daniel González de Requena, Stefano Bonora, Silvia Garazzino et al. · Antimicrobial Agents and Chemotherapy · 2005 · 66 citations

Life Sciences, Pharmacology, Pharmacotherapy +14